STOCK TITAN

Celldex to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) will participate in several virtual investor conferences in November 2021. Notable events include the Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on November 16 at 10:20 a.m. ET, the Jefferies London Healthcare Conference available on-demand starting November 18 at 3:00 a.m. ET, and the Evercore ISI 4th Annual HealthCONx Conference on November 30 at 8:25 a.m. ET. Webcasts of these presentations will be accessible on the Celldex website for 30 days post-event.

Positive
  • None.
Negative
  • None.

HAMPTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following virtual investor conferences in November:

  • Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on Tuesday, November 16, 2021 at 10:20 a.m. ET
  • Jefferies London Healthcare Conference available on-demand beginning Thursday, November 18, 2021 at 3:00 a.m. ET / 8:00 a.m. GMT
  • Evercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 8:25 a.m. ET

Webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. Replays will be available for 30 days following the events.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com


FAQ

When is Celldex participating in the Guggenheim Conference?

Celldex will present at the Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on November 16, 2021, at 10:20 a.m. ET.

What are the dates for Celldex's upcoming investor conferences?

Celldex will be at the Jefferies London Healthcare Conference on November 18, 2021, and the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021.

How can I access the webcasts of Celldex's presentations?

Webcasts of Celldex's presentations will be available on their 'Events & Presentations' page for 30 days after each event.

What time will Celldex's presentation be available during the Jefferies London Conference?

The Jefferies London Healthcare Conference presentation will be available on-demand starting November 18, 2021, at 3:00 a.m. ET / 8:00 a.m. GMT.

Celldex Therapeutics, Inc

NASDAQ:CLDX

CLDX Rankings

CLDX Latest News

CLDX Stock Data

1.71B
66.12M
0.3%
110.23%
11.81%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States of America
HAMPTON